7. Barth, R. J. , Bock, S.N., Mule, J.J. and Rosenberg, S.A.: Unigue murine 
tumor-associated antigens identified by tumor infiltrating lymphocytes. 
J. Immunol . 144:1531-1537, 1990. 
8. Topalian, S.L., Solomon, D. and Rosenberg, S.A.; Tumor-specific cytolysis by 
lymphocytes infiltrating human melanomas. J. Immunol. 142:3714-3725, 1989. 
9. Topalian, S.L. and Rosenberg, S.A. : Tumor-infiltrating lymphocytes: 
Evidence for specific immune reactions against growing cancers in mice and 
humans. In Devita, VT, Heilman, S, Rosenberg, SA (eds.). Important 
Advances in Oncology 1991 (in press). 
* 
10. Griffith, K.D., Read, E. J. , Carrasquillo , J.A., Carter, C.S. , Yang, J.C., 
Fisher, B. , Aebersold, P. , Packard, B.S., Yu, M.Y. and Rosenberg, S.A.: 
In vivo distribution of adoptively transferred Indium-lll-labeled tumor 
infiltrating lymphocytes and peripheral blood lymphocytes in patients with 
metastatic melanoma, J Natl Cancer Inst 8 1:1709-1717, 1989. 
11. Carswell, E.A. , Old, L. J, , kassel, R.C., Green, S. , Fiore, N. and Williamson, 
B.D.: An endotoxin-induced serum factor that causes necrosis of tumors. 
Proc. Natl. Acad. Sci. USA, 72:3666-3670, 1975, 
12. Wang, A.M. , Creasy, A. A., Ladner, M.B., Lin, L.S., Strickler, J., Van 
Arsdell , J.N. , Yamamoto, R. and Mark, D.F.: Molecular cloning of the 
complementary DNA for human tumor necrosis factor. Science 228:149-154, 
13. Asher, A.L. , Mule, J.J. , Reichert, C.M. , Shiloni, E. and Rosenberg, S.A.: 
Studies of the anti-tumor efficacy of systeraically administered recombinant 
tumor necrosis factor against several murine tumors in vivo. J. Immunol . 
138:963-974, 1987. 
14. McIntosh, J.E., Mule, J.J., Merino, M.J., and Rosenberg, S.A.: Synergistic 
antitumor effects of immunotherapy with recombinant interleukin-2 and re- 
combinant tumor necrosis factor-alpha. Cancer Res . 48:4011-4017, 1988. 
Recombinant DNA Research, Volume 14 
[285] 
